Syed Alam, MD
Vascular Surgery · Battle Creek, MINPI 1619135480
Payments from drug & device makers
What this record shows
This record is dominated by other: $27,979 of the $37,184 with a category attached, or 75.2%. Angiodynamics, Inc. accounts for 76.9% of it on its own, with 37 other manufacturers making up the rest. Among vascular surgery clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 296 payments — averaging $125.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$29K
- W. L. Gore & Associates, Inc.$2K
- Endologix LLC$2K
- Johnson & Johnson$820
- Lemaitre Vascular, Inc.$517
- Medtronic$489
- plus $3K from 32 others
What the payments were for
- Travel & lodging$8802%
- Food & beverage$7,74021%
- Education$5852%
- Other$27,97975%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 28 | $28,599 |
| W. L. Gore & Associates, Inc. | 18 | $1,786 |
| Endologix LLC | 11 | $1,697 |
| Johnson & Johnson(2 entities) | 54 | $820 |
| Lemaitre Vascular, Inc. | 11 | $517 |
| Medtronic(2 entities) | 23 | $489 |
| Smith+Nephew | 21 | $425 |
| Bolton Medical Inc | 6 | $367 |
| Philips North America LLC | 16 | $337 |
| Cardiovascular Systems Inc. | 25 | $296 |
| Cook Medical LLC | 16 | $281 |
| Bard Peripheral Vascular, Inc. | 9 | $255 |
| Pfizer | 10 | $176 |
| Cordis US CORP. | 3 | $134 |
| Cardinal Health 200 LLC | 6 | $103 |
| Convatec Inc. | 3 | $89 |
| E.r. Squibb & Sons, L.L.C. | 5 | $83 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $78 |
| Stryker | 1 | $65 |
| Abbott | 3 | $61 |
| Esperion Therapeutics, Inc. | 2 | $52 |
| BD | 1 | $51 |
| Getinge USA Sales, LLC | 3 | $48 |
| Amgen | 2 | $42 |
| Surgenex LLC | 2 | $39 |
| Solventum Corporation | 2 | $38 |
| Boston Scientific | 2 | $38 |
| KCI USA, Inc. | 2 | $25 |
| Organogenesis Inc. | 1 | $24 |
| Terumo Medical Corporation | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Melinta Therapeutics, LLC | 1 | $21 |
| Mimedx Group, Inc. | 1 | $21 |
| Acelrx Pharmaceuticals, Inc. | 1 | $19 |
| Reflow Medical Inc | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $18 |
| Avenu Medical Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$28,093
- Alto Abdominal Stent Graft System$1,277
- EXCLUDER Iliac Branch Endoprosthesis$813
- EXCLUDER AAA Endoprosthesis$312
- GORE VIABAHN Endoprosthesis with Heparin$170
- AFX2 Bifurcated Endograft System$150
- Ovation iX Iliac Stent Graft$150
- RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$148
- Relay Plus$137
- MYNXGRIP$125
- GORE VIABAHN Endoprosthesis$121
- RESTOREFLOW$113
- ENDOCROSS Device$109
- Torus Stent Graft System$109
- inCourage$104
- GORE VIABAHN VBX Balloon Expandable Endo$102
How this compares
$37,184 in reported general payments places this provider in the 90th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 35 | $34,500 |
| EliquisApixaban | 25 | $17,895 |
| ClopidogrelClopidogrel Bisulfate | 196 | $3,036 |
| Cephalexin | 29 | $436 |
| Doxycycline Hyclate | 13 | $173 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $169 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $820 | $34,50035 claims |
| PfizerEliquis | $176 | $17,89525 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 183 vascular surgery providers in Michigan.
Other vascular surgery in Battle Creek
- Abedelkarim AbushmaiesBattle Creek$75K
- Tarek ElshaarawyBattle Creek$32K
- Stephanie BuiBattle Creek$7K
- Nicolas MouawadWest Branch$1.7M
- Enrique Criado PallaresMidland$800K
- Jordan KnepperEast Lansing$336K
- Joseph CuppariClinton Township$98K
- Eanas YassaGrand Rapids$81K
- Kevin OnofreyDetroit$65K
- Yevgeniy RitsDetroit$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.